WS
ICPT

Wedbush Securities’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Wedbush Securities’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-6,611
Closed -$274K – 1009
2020
Q3 		$274K Buy
6,611
+191
+3% +$8.78K 0.03% 652
2020
Q2 		$308K Buy
+6,420
New +$496K 0.03% 596
2020
Q1 		– Sell
-2,990
Closed -$371K – 1029
2019
Q4 		$371K Sell
2,990
-4,946
-62% -$443K 0.03% 587
2019
Q3 		$527K Buy
7,936
+957
+14% +$64.3K 0.05% 427
2019
Q2 		$555K Buy
6,979
+1,790
+34% +$160K 0.06% 389
2019
Q1 		$580K Buy
5,189
+635
+14% +$69.4K 0.06% 363
2018
Q4 		$459K Buy
4,554
+1,080
+31% +$112K 0.06% 386
2018
Q3 		$439K Buy
3,474
+357
+11% +$37.8K 0.05% 447
2018
Q2 		$262K Sell
3,117
-2,605
-46% -$191K 0.03% 609
2018
Q1 		$352K Buy
5,722
+50
+0.9% +$3.01K 0.05% 475
2017
Q4 		$331K Buy
+5,672
New +$358K 0.04% 510
2017
Q3 		– Sell
-2,395
Closed -$290K – 882
2017
Q2 		$290K Buy
2,395
+310
+15% +$35.9K 0.04% 556
2017
Q1 		$236K Sell
2,085
-285
-12% -$33.3K 0.03% 628
2016
Q4 		$258K Buy
2,370
+75
+3% +$8.94K 0.04% 566
2016
Q3 		$378K Buy
2,295
+35
+2% +$5.52K 0.06% 421
2016
Q2 		$322K Buy
2,260
+40
+2% +$5.83K 0.05% 431
2016
Q1 		$285K Buy
2,220
+125
+6% +$14.8K 0.05% 447
2015
Q4 		$313K Sell
2,095
-65
-3% -$11K 0.06% 387
2015
Q3 		$358K Sell
2,160
-8
-0.4% -$1.76K 0.07% 314
2015
Q2 		$523K Buy
2,168
+28
+1% +$7.46K 0.1% 248
2015
Q1 		$604K Sell
2,140
-75
-3% -$16.2K 0.1% 224
2014
Q4 		$346K Buy
+2,215
New +$409K 0.05% 359

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Wedbush Securities's ICPT Position: Q4 2020 in Review

Wedbush Securities sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2020, closing a stake of 6,611 shares — an estimated $274K sold.

Wedbush Securities first reported a position in ICPT in Q4 2014 and held it in 22 quarters. The position peaked at $604K in Q1 2015. 175 funds tracked by Wall St. Rank hold ICPT as of Q4 2020.

  • Wedbush Securities reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Wedbush Securities sold 6,611 Intercept Pharmaceuticals, Inc. shares in Q4 2020, an estimated $274K.
  • Wedbush Securities first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2014 and held it in 22 quarters.
  • Wedbush Securities's Intercept Pharmaceuticals, Inc. position peaked at $604K in Q1 2015.
  • 175 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2020.

Based on Wedbush Securities's 13F filing for Q4 2020, filed 16 Feb 2021.